Stay updated on Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial
Sign up to get notified when there's something new on the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page.

Latest updates to the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA dedicated Locations section now lists California and Florida sites for the study. The previous 'California Locations' and 'Florida Locations' entries and the 'HHS Vulnerability Disclosure' link were removed.SummaryDifference0.4%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedFooter Revision updated from v3.2.0 to v3.3.2 with no changes to study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check56 days agoChange DetectedThe site-wide government funding status notice has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedThe screenshots show only minor UI/layout updates and banner changes, with no modifications to the study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check99 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference5%

- Check107 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.1%

Stay in the know with updates to Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fevipiprant PK in Hepatic Impairment vs Healthy Subjects Clinical Trial page.